mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |